Edition:
United States

NuVasive Inc (NUVA.OQ)

NUVA.OQ on NASDAQ Stock Exchange Global Select Market

52.18USD
4:00pm EDT
Change (% chg)

$1.36 (+2.68%)
Prev Close
$50.82
Open
$50.80
Day's High
$53.01
Day's Low
$50.80
Volume
651,600
Avg. Vol
369,394
52-wk High
$81.48
52-wk Low
$49.25

Latest Key Developments (Source: Significant Developments)

NuVasive receives expanded FDA 510(k) clearance for innovative magnetic limb lengthening technology
Thursday, 12 Oct 2017 08:30am EDT 

Oct 12 (Reuters) - Nuvasive Inc ::NuVasive receives expanded FDA 510(k) clearance for innovative magnetic limb lengthening technology.Says ‍received expanded 510(K) clearance from U.S. FDA for co's precice system​.Says the ‍system is now indicated for bone transport of long bones in addition to limb lengthening​.  Full Article

NuVasive files lawsuit against Patrick S. Miles
Tuesday, 10 Oct 2017 04:36pm EDT 

Oct 10 (Reuters) - Alphatec Holdings Inc :Nuvasive files lawsuit against patrick s. Miles to protect corporate assets and stakeholders' interests.Nuvasive inc - ‍filed a lawsuit in delaware chancery court against patrick s. Miles, former vice chairman of co and member of co's board of directors​.Nuvasive inc says lawsuit asserts that ‍miles' resignation from co was "in violation of his contractual obligations to nuvasive"​.  Full Article

NuVasive says ‍commercial launch of its lessray software technology system​
Wednesday, 13 Sep 2017 07:31am EDT 

Sept 13 (Reuters) - NuVasive Inc :Nuvasive Inc - ‍commercial launch of its Lessray Software technology system​.  Full Article

Nuvasive buys privately-held medical device co Vertera Spine
Thursday, 7 Sep 2017 10:43am EDT 

Sept 7 (Reuters) - Nuvasive Inc ::Nuvasive announces acquisition of Vertera Spine.Terms of acquisition were not disclosed​​.‍Announced acquisition of Vertera Spine, a privately-held medical device company​.Vertera Spine's existing interbody product lines will be added to Nuvasive's portfolio for U.S. commercial sale and distribution​.  Full Article

Nuvasive receives FDA 510(K) clearance for leading EOS innovation
Wednesday, 6 Sep 2017 08:00am EDT 

Sept 6 (Reuters) - Nuvasive Inc :Nuvasive receives FDA 510(K) clearance for leading EOS innovation.  Full Article

Nuvasive announces new organizational structure
Thursday, 27 Jul 2017 04:05pm EDT 

July 27 (Reuters) - Nuvasive Inc :Announces new organizational structure.Nuvasive Inc says it has accepted resignation of its CFO Quentin Blackford, effective August 25, 2017.Nuvasive - Vickie Capps, independent member of co's board, will provide guidance and support to co's financial organization during transition period.Says Jason Hannon, president and chief operating officer, is stepping down from his position.Nuvasive Inc - new structure designed to align strategy and innovation, integrate global commercial channels and transform business operations.  Full Article

Nuvasive Q2 earnings per share $0.22
Thursday, 27 Jul 2017 04:02pm EDT 

July 27 (Reuters) - Nuvasive Inc :Nuvasive reports second quarter 2017 financial results.Q2 non-gaap earnings per share $0.46.Q2 gaap earnings per share $0.22.Q2 revenue rose 10.3 percent to $260.6 million.Says company reiterates revenue, non-gaap operating margin and non-gaap diluted earnings per share guidance for 2017.FY 2017 earnings per share view $2.01, revenue view $1.07 billion -- Thomson Reuters I/B/E/S.  Full Article

NuVasive reports Q1 gaap earnings per share $0.22
Tuesday, 25 Apr 2017 04:05pm EDT 

April 25 (Reuters) - NuVasive Inc -:NuVasive announces first quarter 2017 financial results.Q1 non-gaap earnings per share $0.38.Q1 gaap earnings per share $0.22.Q1 revenue rose 16.2 percent to $250 million.NuVasive Inc says amended its existing revolving line of credit to expand facility from $150 million up to $500 million.Reiterated full year 2017 guidance.NuVasive Inc - expects expanded facility to allow "greater flexibility" in planning for maturity of its convertible notes due july 2017.Q1 earnings per share view $0.38, revenue view $250.9 million -- Thomson Reuters I/B/E/S.Fy2017 earnings per share view $2.02, revenue view $1.07 billion -- Thomson Reuters I/B/E/S.  Full Article

NuVasive announces FDA 510(K) clearance of Coroent small interbody system
Wednesday, 29 Mar 2017 09:00am EDT 

Nuvasive Inc :NuVasive - announced fda 510(K) clearance of coroent small interbody system indicated for intervertebral body fusion at contiguous levels in cervical spine.  Full Article

New evidence-based recommendation released from NICE (U.K.) for lateral interbody fusion
Monday, 20 Mar 2017 09:00am EDT 

Nuvasive Inc : New evidence-based recommendation released from NICE (U.K.) for lateral interbody fusion .NICE stated evidence on efficacy for lateral interbody fusion is adequate in quality and quantity.  Full Article

BRIEF-NuVasive receives expanded FDA 510(k) clearance For TLX Interbody System used in TLIF procedures

* NuVasive receives expanded FDA 510(k) clearance For TLX Interbody System used in TLIF procedures